X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12) 12
index medicus (12) 12
article (8) 8
egfr (7) 7
lung cancer (7) 7
middle aged (7) 7
respiratory system (7) 7
adenocarcinoma (6) 6
aged (6) 6
alk (6) 6
female (6) 6
lung neoplasms - genetics (6) 6
male (6) 6
non-small-cell lung cancer (6) 6
oncology (6) 6
pulmonary/respiratory (6) 6
anaplastic lymphoma kinase (5) 5
hematology, oncology and palliative medicine (5) 5
surgery (5) 5
carcinoma, non-small-cell lung - genetics (4) 4
epidermal growth factor receptor (4) 4
genotype (4) 4
lung cancer, non-small cell (4) 4
never smokers (4) 4
receptor, epidermal growth factor - genetics (4) 4
tumor genotype (4) 4
adult (3) 3
analysis (3) 3
bone specimen (3) 3
core biopsy (3) 3
erlotinib (3) 3
failure (3) 3
growth-factor receptor (3) 3
internship and residency (3) 3
kras (3) 3
lung neoplasms - drug therapy (3) 3
medical colleges (3) 3
molecular testing (3) 3
mutation (3) 3
receptor protein-tyrosine kinases - genetics (3) 3
retrospective studies (3) 3
tumors (3) 3
abridged index medicus (2) 2
adenocarcinoma - genetics (2) 2
aged, 80 and over (2) 2
attitude of health personnel (2) 2
cell line, tumor (2) 2
computed tomography (2) 2
curriculum (2) 2
driver oncogene (2) 2
endobronchial ultrasound (2) 2
gefitinib (2) 2
general surgery - education (2) 2
genetic aspects (2) 2
kras mutations (2) 2
learning (2) 2
lung neoplasms - diagnosis (2) 2
mediastinoscopy (2) 2
medicine (2) 2
molecular-pathology (2) 2
multidisciplinary sciences (2) 2
neoplasm staging (2) 2
next generation sequencing (2) 2
proto-oncogene proteins - genetics (2) 2
proto-oncogene proteins p21 (2) 2
qualitative research (2) 2
ras proteins - genetics (2) 2
squamous cell carcinomas (2) 2
students (2) 2
studies (2) 2
surgeons (2) 2
teaching (2) 2
transbronchial needle aspiration (2) 2
activation (1) 1
adaptive immunity (1) 1
additive manufacturing (1) 1
adenocarcinoma - diagnosis (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma of lung (1) 1
adenocarcinomas (1) 1
african americans - genetics (1) 1
analgesics (1) 1
analgesics - therapeutic use (1) 1
anesthesia (1) 1
animals (1) 1
anti-pd-l1 antibody (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic agents - therapeutic use (1) 1
antitumor immunity (1) 1
asian (1) 1
asian americans - genetics (1) 1
b7-h1 antigen - administration & dosage (1) 1
b7-h1 antigen - immunology (1) 1
biocompatibility (1) 1
biocompatible materials - chemistry (1) 1
biomarker testing (1) 1
biomaterial (1) 1
biopsy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Chest, ISSN 0012-3692, 10/2010, Volume 138, Issue 4, pp. 784A - 784A
Journal Article
Chest, ISSN 0012-3692, 10/2010, Volume 138, Issue 4, pp. 53A - 53A
Journal Article
Lung Cancer, ISSN 0169-5002, 2014, Volume 84, Issue 1, pp. 39 - 44
Journal Article
Lung Cancer, ISSN 0169-5002, 02/2018, Volume 116, pp. 90 - 95
Although a growing list of essential genomic/immune-based biomarkers are linked to approved non-small-cell lung cancer (NSCLC) therapies worldwide, few reports... 
Adenocarcinoma | ALK | Biomarker testing | Smoking history | Lung cancer | EGFR | ONCOLOGY | RESPIRATORY SYSTEM | ADENOCARCINOMAS | Lung cancer, Non-small cell | Analysis | Tumors | Smoking | Keywords: lung cancer | adenocarcinoma | smoking history | biomarker testing
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e19109 - e19109
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 11/2013, Volume 8, Issue 11, pp. 1438 - 1444
Adequate tumor acquisition is essential to identify somatic molecular alterations in non–small-cell lung cancer (NSCLC), such as epidermal growth factor... 
Non–small-cell lung cancer | Kirsten rat sarcoma viral oncogene homolog | Lung cancer | Tumor genotype | Molecular testing | Mediastinoscopy | Endobronchial ultrasound | Epidermal growth factor receptor | Core biopsy | Computed tomography | Never smokers | Anaplastic lymphoma kinase | Bone specimen | Transbronchial needle aspiration | Failure | Nonsmall-cell lung cancer | MUTATION ANALYSIS | FEASIBILITY | Non-small-cell lung cancer | EGFR | GROWTH-FACTOR RECEPTOR | ONCOLOGY | RESPIRATORY SYSTEM | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Lymph Nodes - pathology | Prognosis | Endosonography | Follow-Up Studies | Carcinoma, Squamous Cell - genetics | Humans | Middle Aged | Male | Carcinoma, Non-Small-Cell Lung - diagnosis | Carcinoma, Squamous Cell - diagnosis | Polymerase Chain Reaction | Aged, 80 and over | Bronchi - metabolism | Adult | Female | Adenocarcinoma - genetics | Retrospective Studies | Bronchi - pathology | Bronchi - diagnostic imaging | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Lymph Nodes - metabolism | Genotype | Proto-Oncogene Proteins - genetics | Mutation - genetics | Biopsy, Fine-Needle | Adenocarcinoma - diagnosis | Aged | Lung Neoplasms - diagnosis | Neoplasm Staging | Lymph Nodes - diagnostic imaging
Journal Article
Lung Cancer, ISSN 0169-5002, 2016, Volume 99, pp. 17 - 22
Journal Article
Journal of Bronchology and Interventional Pulmonology, ISSN 1944-6586, 07/2013, Volume 20, Issue 3, pp. 290 - 292
Journal Article
Lung Cancer, ISSN 0169-5002, 2013, Volume 82, Issue 1, pp. 31 - 37
Abstract Introduction The identification of somatic genomic aberrations in non-small-cell lung cancer (NSCLC) is part of evidence-based practice guidelines for... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | ALK | Lung cancer | Non-small-cell lung cancer | KRAS | Never smokers | Anaplastic lymphoma kinase | Epidermal growth factor receptor | EGFR | GENE-MUTATIONS | EGFR-MUTATION | GEFITINIB | ADENOCARCINOMA | KRAS MUTATIONS | TRIAL | GROWTH-FACTOR RECEPTOR | THERAPY | ONCOLOGY | RESPIRATORY SYSTEM | ERLOTINIB | Smoking - adverse effects | Lung Neoplasms - ethnology | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | United States | Humans | Middle Aged | Carcinoma, Non-Small-Cell Lung - etiology | Male | Lung Neoplasms - etiology | DNA Mutational Analysis | Aged, 80 and over | Adult | Female | Retrospective Studies | Oncogenes | Lung Neoplasms - genetics | European Continental Ancestry Group - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Gene Frequency | Self Report | Hospitals, University | African Americans - genetics | Carcinoma, Non-Small-Cell Lung - ethnology | Proto-Oncogene Proteins - genetics | Asian Americans - genetics | Receptor Protein-Tyrosine Kinases - genetics | Aged | Medicine | Practice | Lung cancer, Non-small cell | epidermal growth factor receptor | anaplastic lymphoma kinase | Black | tumor genotype | Asian | ethnicipty | lung cancer | White | never smokers | non-small-cell lung cancer
Journal Article
Lung Cancer, ISSN 0169-5002, 2015, Volume 88, Issue 1, pp. 70 - 73
Highlights • EGFR mutations occur in some high-grade neuroendocrine lung cancers. • EGFR protein is not expressed in EGFR mutated neuroendocrine lung cancers.... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | Never-smoker | Progression | Resistance | Small cell lung cancer | Erlotinib | Large cell neuroendocrine carcinoma | Mutation | EGFR | GEFITINIB | ADENOCARCINOMA | LUNG CANCERS | MOLECULAR-PATHOLOGY | ONCOLOGY | RESPIRATORY SYSTEM | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Small Cell Lung Carcinoma - drug therapy | Carboplatin - therapeutic use | Fatal Outcome | Female | Antineoplastic Agents - pharmacology | Lung Neoplasms - genetics | Carcinoma, Neuroendocrine - drug therapy | Etoposide - pharmacology | Carcinoma, Neuroendocrine - genetics | Etoposide - therapeutic use | Small Cell Lung Carcinoma - genetics | Disease Progression | Radiography | Erlotinib Hydrochloride - pharmacology | Carcinoma, Neuroendocrine - diagnostic imaging | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Small Cell Lung Carcinoma - diagnostic imaging | Lung Neoplasms - diagnostic imaging | Aged | Erlotinib Hydrochloride - therapeutic use | Carboplatin - pharmacology | Lung cancer | Genetic aspects | Cancer | Antimitotic agents | Tyrosine | Analysis | Lung cancer, Non-small cell | Antineoplastic agents | lung cancer | mutation | erlotinib | progression | small cell lung cancer | never-smoker | large cell neuroendocrine carcinoma | resistance
Journal Article
Journal of the American College of Surgeons, ISSN 1072-7515, 2011, Volume 213, Issue 3, pp. S41 - S41
Journal Article
Journal of the American College of Surgeons, ISSN 1072-7515, 2011, Volume 213, Issue 3, pp. S39 - S39
Journal Article
Chest, ISSN 0012-3692, 10/2009, Volume 136, Issue 4, pp. 80S - 80S
Journal Article
Cancer Treatment Communications, ISSN 2213-0896, 2015, Volume 4, pp. 174 - 181
Abstract Introduction Tumor genotyping using single gene assays (SGAs) is standard practice in advanced non-small-cell lung cancer (NSCLC). We evaluated how... 
Hematology, Oncology and Palliative Medicine | ALK | Adenocarcinoma | Non-small-cell lung cancer | Squamous cell carcinomas | Genotype | Driver oncogene | Next generation sequencing | MET | ROS1 | EGFR | next generation sequencing | adenocarcinoma | driver oncogene | squamous cell carcinomas | genotype
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.